title: EPHA7 and EPHA10 Physically Interact and Differentially Co-localize in Normal Breast and Breast Carcinoma Cell Lines, and the Co-localization Pattern Is Altered in EPHB6-expressing MDA-MB-231 Cells.
abstract: Erythropoietin-producing hepatocellular carcinoma cell (EPH) receptors comprise the most abundant receptor tyrosine kinase family characterized to date in mammals including humans. These proteins are involved in axon guidance, tissue organization, vascular development and the intricate process of various diseases including cancer. These diverse functions of EPH receptors are attributed, in part, to their abilities for heterodimerization. While the interacting partners of kinase-deficient EPHB6 receptor have been characterized, the interaction of the kinase-dead EPHA10 with any other receptor has not been identified. By using co-immunoprecipitation, we demonstrated physical interaction between kinase-deficient EPHA10 with kinase-sufficient EPHA7 receptor. Immunocytochemical analyses have revealed that these two receptors co-localize on the cell surface, and soluble portions of the receptors exist as a complex in the cytoplasm as well as the nuclei. While EPHA7 and EPHA10 co-localize similarly on the membrane in MCF10A and MCF7 cells, they were differentially co-localized in MDA-MB-231 cells stably transfected with empty pcDNA vector (MDA-MB-231-PC) or an expression construct of EPHB6 (MDA-MB-231-B6). The full-length isoforms of these receptors were co-localized on the cell surface, and the soluble forms were present as a complex in the cytoplasm as well as the nucleus in MDA-MB-231-PC cells. MDA-MB-231-B6 cells, on the other hand, were distinguished by the absence of any signal in the nuclei. Our results represent the first demonstration of physical interaction between EPHA10 and EPHA7 and their cellular co-localization. Furthermore, these observations also suggest gene-regulatory functions of the complex of the soluble forms of these receptors in breast carcinoma cells of differential invasiveness.
authors: Department of Basic Medical Sciences, Western University of Health Sciences, Pomona, CA, U.S.A.
authors: Candace
authors: C
authors: Johnson
authors: Department of Basic Medical Sciences, Western University of Health Sciences, Pomona, CA, U.S.A.
authors: Briana
authors: B
authors: Segovia
authors: Department of Basic Medical Sciences, Western University of Health Sciences, Pomona, CA, U.S.A. rkandpal@westernu.edu.
authors: Raj P
authors: RP
authors: Kandpal
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics / Q000378:metabolism*; D045744:Cell Line, Tumor; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D011485:Protein Binding; D020033:Protein Isoforms; D021381:Protein Transport; D036141:Receptor, EphA7 / Q000378:metabolism*; D036261:Receptor, EphB6 / Q000235:genetics*; D036081:Receptors, Eph Family / Q000378:metabolism*
chemical_list: D020033:Protein Isoforms; D036261:Receptor, EphB6; C568447:EPHA10 protein, human; D036141:Receptor, EphA7; D036081:Receptors, Eph Family
keywords: Breast cancer; EPH receptors; EPHA10; EPHA7; breast carcinoma cells; cellular co-localization; co-immunoprecipitation; protein-protein interaction